57 results on '"Rigó, M"'
Search Results
2. Influence of the valve on the performance of two cylindrical valved holding chambers
3. Prediction of the particle size distribution of the aerosol generated by a pressurized metered-dose inhaler
4. A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study
5. Development of porous spray-dried inhalable particles using an organic solvent-free technique
6. Modelling of the spray drying process for particle design
7. Another generalization of abelian equivalence: Binomial complexity of infinite words
8. Lavini di Marco (Trentino, Italy): 36Cl exposure dating of a polyphase rock avalanche
9. About frequencies of letters in generalized automatic sequences
10. PO-2350 Evaluation of AI based synthetic CT generation solutions for T2w pelvis MRIs
11. PO-2337 Evaluation of AI based CT auto-contouring on synthetic CTs as an indicator for synthesis quality
12. PO-1601 Stereotactic body radiotherapy (SBRT) with or without dose boost in spinal oligometastatic patients
13. PO-1540 1.5T MR-guided daily-adapted SBRT on lymphnode oligometastases from prostate cancer
14. PO-1530 Prostate SBRT on 1.5T MR-linac or linac-based VMAT: a comparison study from a prospective trial
15. PO-1485 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 5000 fractions
16. PO-1486 Feasibility and tolerability of MR-guided adaptive RT on prostatic bed:mono-institutional experience
17. PO-1134 Repeated SRS with linac-based monoisocentric technique in recurrent intracranial metastases
18. P077 - 1.5T MR-guided daily-adapted stereotactic body radiotherapy for prostate re-irradiation: A preliminary report of toxicity and clinical outcomes
19. P038 - Toxicity patterns and preliminary clinical outcomes of 1.5T MR-guided stereotactic body radiotherapy for prostate cancer
20. PO-1463 SBRT for over 80years oligometastatic patients: report of feasibility and clinical outcomes
21. PO-1452 Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
22. PO-1407 Postoperative hypofractionated RT: toxicity and efficacy in a series of 304 prostate adenocarcinoma
23. PO-1353 SBRT for gynecological oligometastases: mono-institutional report of toxicity and clinical outcomes
24. PO-1188 Stereotactic body RT (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer
25. PD-0571 Determining interobserver variability in prostate bed CTV target delineation using MRI
26. PD-0575 Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
27. PD-0574 1.5T MR-guided RT versus linac-based VMAT SBRT in localized prostate cancer: a toxicity comparison
28. PD-0250 Therapeutic use of Linac-based SRS in malignant spasticity: early results from a prospective trial
29. PD-0086 PSMA-PET guided stereotactic body radiotherapy for bone oligorecurrent prostate cancer
30. OC-0602 A pREDictive model of polymetastatic disease on oligometastatic colorectal cancer: the RED LaIT-SABR
31. EP014 - Preliminary report of toxicity and quality of life of the first 100 patients treated with 1.5T MR-guided stereotactic body radiotherapy for prostate cancer
32. EP015 - PSMA-guided SBRT for bone oligometastatic prostate cancer: a monoinstitutional report of preliminary outcomes and toxicity
33. EP013 - Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intra-fraction motion during 1.5 t-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancer
34. PO-1512 Daily adaptive MR-guided SBRT for oligometastatic lymph-nodes:feasibility and preliminary experience
35. PO-1499 1.5T MR-guided daily adaptive radiotherapy: preliminary clinical report of the first 2000 fractions.
36. PO-1439 Clinical results of SBRT for spinal metastases using dedicated contouring/planning system
37. PO-1388 1.5 T MR-guided SBRT for oligorecurrent prostate cancer: preliminary report of feasibility and PROMs
38. PO-1376 Preliminary mono-institutional report of prostate/prostate bed SBRT re-irradiation
39. PO-1353 Postoperative hypofractionated RT for prostate adenocarcinoma: results from a large series
40. PO-1153 Preliminary mono-institutional report of stereotactic body radiotherapy for lung oligometastases
41. PH-0112 Multicenter large retrospectIve database on SBRT for colorectal lung metastases: the LaIT-SABR study
42. PD-0863 Preliminary dosimetric report of 1.5-T MR-guided daily-adaptive SBRT for lymph-nodal oligometastases
43. P043 - Geriatric assessment tools and preliminary patient-reported outcomes in a cohort of elderly patients treated with 1.5T MR-guided and daily adapted abdominal-pelvic SBRT
44. P030 - Metastasis-directed Stereotactic Body Radiotherapy (SBRT)-guided by pet-ct 18f-choline versus pet-ct 68ga-psma in castration sensitive oligorecurrent prostate cancer: A comparative effectiveness analysis
45. P029 - Linac-based SBRT for local recurrent prostate cancer after previous radiotherapy
46. PO-1841: Efficacy of a new dedicated immobilization device for treatment of Central Nervous disease
47. PO-1193: 18F-CHOLINE PET/68Ga-PSMA PET SBRT in oligorecurrent prostate cancer: comparative analysis
48. PO-1163: 68Ga-PSMA PET-Guided metastases directed stereotactic body radiotherapy in prostatic cancer patients
49. PO-1162: Post hifu salvage radiotherapy in locally relapsed prostate carcinoma: a mono-institutional analysis
50. PO-1062: Stereotactic body radiotherapy can delay polymetastatic conversion in liver oligometastatic patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.